BTIG Sees Billion-Dollar Potential in Absci’s AI-Designed Hair Loss Antibody
The intersection of artificial intelligence and drug discovery has long been promised as the next frontier in medicine, but recent developments in the biotechnology sector are bringing that potential into sharper focus. Specifically, investors and industry analysts are closely monitoring advancements in protein design, with companies like Absci Corporation attracting significant attention for their proprietary … Read more
